IP Library Granted Patent US 8,993,722
Granted Patent B2
US 8,993,722 · App. 12/671,082 · Granted Mar 31, 2015

Process for the preparation glatiramer acetate (copolymer-1)

Inventors: Satyanarayana Kota (Hyderabad, IN); Venkateswarlu Tallapaneni (Hyderabad, IN); Bhujanga rao Adibhatla Kali Satya (Hyderabad, IN); Nannapaneni Venkaiah Chowdary (Hyderabad, IN)
Assignee: Natco Pharma Limited
C07K14/001C08G69/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,993,722
App. No.
12/671,082
Granted
Mar 31, 2015
Kind
B2
Abstract

This invention relates to a convenient and improved process for preparation of glatiramer acetate (copolymer-1) of pharmaceutical grade. The process involves polymerizing N-carboxyanhydrides of tyrosine, alanine, y-benzyl glutamate and ε-N-trifluoroacetyllysine in dioxane with diethylamine as initiator to afford protected copolymer-1. Treatment with hydrogen bromide in acetic acid at 35° C. for 3-5 h cleaves benzyl group to produce trifluoroacetyl copolymer-1. The trifluoroacetyl copolymer-1 is washed with an organic solvent to remove reactive benzyl bromide generated during debenzylation. Deprotection with aqueous piperidine, followed by dialysis offers glatiramer acetate (copolymer-1) of Molecular weight 5000-9000 daltons.

Claims (15)

1. A process for preparing copolymer-1, comprising:

reacting protected copolymer-1 with hydrobromic acid for 1 to 5 hr at 35-45° C. to form trifluoroacetyl copolymer-1;

washing the trifluoroacetyl copolymer-1 with organic solvent, thus removing benzyl bromide, wherein the organic solvent comprises a hydrocarbon, a halogenated hydrocarbon, an alcohol, an ether, or an ester;

treating the trifluoroacetyl copolymer-1 with aqueous piperidine to form copolymer-1; and

purifying the copolymer-1;

wherein copolymer-1 has a molecular weight of 5,000 to 9,000 Daltons and is glatiramer acetate comprising a mixture of polypeptides composed of glutamic acid, alanine, tyrosine, and lysine in a molar ratio of approximately of 0.141, 0.427, 0.095 and 0.338.

2. The method of claim 1 , comprising reacting the protected copolymer 1 with hydrobromic acid for 3 hr at 35-45° C.

3. The method of claim 1 , wherein the organic solvent comprises diisopropyl ether, diethyl ether, or ethyl acetate.

4. A process for preparing copolymer-1, comprising:

reacting protected copolymer-1 with hydrobromic acid for 1 to 5 hr at 35-45° C. to form trifluoroacetyl copolymer-1;

washing the trifluoroacetyl copolymer-1 with diisopropyl ether, diethyl ether, or ethyl acetate, thus removing benzyl bromide;

treating the trifluoroacetyl copolymer-1 with aqueous piperidine to form copolymer-1; and

purifying the copolymer-1;

wherein copolymer-1 has a molecular weight of 5,000 to 9,000 Daltons and is glatiramer acetate comprising a mixture of polypeptides composed of glutamic acid, alanine, tyrosine, and lysine in a molar ratio of approximately of 0.141, 0.427, 0.095 and 0.338.

5. The method of claim 4 , comprising reacting the protected copolymer 1 with hydrobromic acid for 3 hr at 35-45° C.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2010
From: KOTA, SATYANARAYANA; TALLAPANENI, VENKATESWARLU; ADIBHATLA KALI SATYA, BHUJANGA RAO; VANKAIAH CHOWDARY, NANNAPANENI
To: NATCO PHARMA LIMITED
Reel/Frame 024513/0782 →
Priority Claims (1)
IN 1673/CHE/2007 · Jul 31, 2007 · national
Continuity (1)
Related Publication 20100324265A1 · Dec 23, 2010